CA3086611C — A crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereof
Assigned to Crystal Pharmaceutical Suzhou Co Ltd · Expires 2023-07-25 · 3y expired
What this patent protects
A crystal form of Valbenazine di-p-toluenesulfonate, a preparation method therefor, a pharmaceutical composition comprising the crystal form, and a use of the crystal form in the preparation of a vesicular monoamine transporter 2 inhibitor and a pharmaceutical preparation for tre…
USPTO Abstract
A crystal form of Valbenazine di-p-toluenesulfonate, a preparation method therefor, a pharmaceutical composition comprising the crystal form, and a use of the crystal form in the preparation of a vesicular monoamine transporter 2 inhibitor and a pharmaceutical preparation for treating tardive dyskinesia.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.